Lytica Therapeutics

Adcytherix

This biopharmaceutical company develops novel antibody-drug conjugates to treat various forms of cancer for patients with high unmet clinical needs.

Araris Biotech

This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.

LigaChem Biosciences

This biopharmaceutical company develops antibody-drug conjugates and immuno-oncology therapeutics for global pharmaceutical partners and patients with unmet medical needs.

Mablink Bioscience

This biotechnology firm develops antibody-drug conjugates for pharmaceutical companies to treat cancer using a proprietary hydrophilic linker platform.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Firefly Bio

This biotechnology company develops degrader antibody conjugates to treat cancer patients by combining targeted antibodies with protein degrader technology.

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.

Promatix

Promatix develops antibody-drug conjugates for cancer treatment using a proprietary multi-omics platform to identify and target specific tumour markers.